News FDA OKs Fluocinolone Intravitreal Implant (Yutiq) for Uveitis by Medscape • 2018/10/17 • 0 Comments In clinical trials, Yutiq significantly reduced recurrence rates at 6 and 12 months following treatment compared with sham treatment in patients with chronic, noninfectious posterior segment uveitis. FDA Approvals Full Story →